China’s biopharma industry is in ‘prime position’ to challenge U.S. dominance
By
In
China’s biopharma industry is in ‘prime position’ to challenge U.S. dominance2026-01-032026-01-03https://multipluralworld.com/wp-content/uploads/2024/02/mpw-logo-final-website.pngThe Multiplural Worldhttps://multipluralworld.com/wp-content/uploads/2024/02/mpw-logo-final-website.png200px200px
